Closing the Vaccination Gaps
We help healthcare systems, organizations, and businesses close vaccination gaps — reducing preventable disease, healthcare costs, and workforce absence.
GAPS
COVID-19
13% of adults aged 60+ received a COVID-19 vaccination during the 2024/25 season in Germany. Vaccination uptake among older adults has declined significantly despite continued risk of severe disease, hospitalization, long COVID, and workforce-related absence during seasonal waves.
Influenza
34% of adults aged 60+ received an influenza vaccination during the 2024/25 season. Influenza remains one of the most important drivers of seasonal workforce absence and preventable hospitalization among older adults.
Herpes Zoster
24% of adults aged 60+ were fully vaccinated against herpes zoster in Q1 2025. Despite the high burden of shingles and postherpetic neuralgia in older adults, vaccination uptake remains critically low.
Pneumococcal Disease
14% of adults aged 60–64 were vaccinated against pneumococcal disease. Vaccination coverage remains insufficient despite the risk of severe pneumonia, hospitalization, and invasive pneumococcal disease in older and high-risk populations.
RSV
< 1%* of adults received an RSV vaccination in Germany during the 2024/25 season. Adult RSV vaccination programs are still at an early stage in Germany. Despite the growing relevance of RSV for older adults and healthcare systems during winter seasons, uptake remains critically low.
HPV
55% of 15-year-old girls and 36% of 15-year-old boys were fully vaccinated against HPV in 2024. HPV vaccination remains one of the most important cancer prevention measures, yet vaccination coverage in Germany continues to remain below public health targets.
Source: VacMap, Robert Koch Institute (RKI)
* No official vaccination rate available yet. This estimate is based on vaccine sales data relative to the eligible population size.
VAXGAP
Closing Vaccination Gaps Through Intelligence, Content and Technology
About VaxGap
1
VaxGap is an AI-enabled health intelligence company focused on vaccination prevention. We combine epidemiological data, scientific research, and technology-driven insights to develop evidence-based content and digital solutions for healthcare systems, organizations, and businesses. Our goal is to support data-driven vaccination decisions, systematically address vaccination gaps, and contribute to higher vaccination uptake and better public health outcomes.
Our Mission
2
What we build
3
Strategic insights on vaccination in Germany in under 8 minutes – delivered 10 times per year
HORIZON
The Vaccine Landscape Is Rapidly Evolving
BLOG
Contact VaxGap
For partnerships, collaborations, and strategic inquiries.